Phase I
There were a fair number of clinical trial announcements last week. Here’s a look.
It was a busy week for clinical trial news. Here’s a look.
It was another busy week in clinical trial news. Here’s a look.
XVR011 is being observed in a randomized, double-blind, single-center, and placebo-controlled study to evaluate its pharmacokinetic activity and safety profile.
Moderna is expected to launch a human clinical trial as early as this week for an mRNA-based vaccine against HIV and indicated that it is looking for 56 people ages 18 to 50 who are HIV-negative.
Patient enrollment in the Phase I study will resume, the company announced this morning.
There was plenty of clinical trial updates last week. Here’s a look.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
It was a busy week for clinical trial announcements. Take a look.
With this milestone, the field is now wide open for the next in vivo CRISPR success, and Editas is hoping that it will be in the ocular disease space.
PRESS RELEASES